Literature DB >> 28175954

Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers.

Thomas Efferth1, Manfred Volm2.   

Abstract

The detoxification of toxic substances is of general relevance in all biological systems. The plethora of exogenous xenobiotic compounds and endogenous toxic metabolic products explains the evolutionary pressure of all organisms to develop molecular mechanisms to detoxify and excrete harmful substances from the body. P-glycoprotein and other members of the ATP-binding cassette (ABC) transporter family extrude innumerous chemical compounds out of cells. Their specific expression in diverse biological contexts cause different phenotypes: (1) multidrug resistance (MDR) and thus failure of cancer chemotherapy, (2) avoidance of accumulation of carcinogens and prevention of carcinogenesis in healthy tissues, (3) absorption, distribution, metabolization and excretion (ADME) of pharmacological drugs in human patients, (4) protection from environmental toxins in aquatic organisms (multi-xenobiotic resistance, MXR). Hence ABC-transporters may have opposing effects for organismic health reaching from harmful in MDR of tumors to beneficial for maintenance of health in MXR. While their inhibition by specific inhibitors may improve treatment success in oncology and avoid carcinogenesis, blocking of ABC-transporter-driven efflux by environmental pollutants leads to ecotoxicological consequences in marine biotopes. Poisoned seafood may enter the food-chain and cause intoxications in human beings. As exemplified with ABC-transporters, joining forces in interdisciplinary research may, therefore, be a wise strategy to fight problems in human medicine and environmental sciences.

Entities:  

Keywords:  ABC-transporter; Cancer; Carcinogenesis ecotoxicology; Multi-drug resistance; Multi-xenobiotic resistance

Mesh:

Substances:

Year:  2017        PMID: 28175954     DOI: 10.1007/s00204-017-1938-5

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.

Authors:  Nuha Mahmoud; Mohamed E M Saeed; Yoshikazu Sugimoto; Sabine M Klauck; Henry J Greten; Thomas Efferth
Journal:  Oncotarget       Date:  2018-11-06

2.  Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy.

Authors:  Julia Sachs; Onat Kadioglu; Anja Weber; Vanessa Mundorf; Janina Betz; Thomas Efferth; Jörg Pietruszka; Nicole Teusch
Journal:  J Nat Med       Date:  2018-07-31       Impact factor: 2.343

Review 3.  Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.

Authors:  Armelle T Mbaveng; Victor Kuete; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

4.  Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.

Authors:  Mohamed E M Saeed; Joelle C Boulos; Kevin Machel; Nasim Andabili; Thamail Marouni; Wilfried Roth; Thomas Efferth
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

5.  Mitochondrial autophagosomes as a mechanism of drug resistance in breast carcinoma.

Authors:  Ayman N Abunimer; Heba Mohammed; Katherine L Cook; David R Soto-Pantoja; Maria Mercedes Campos; Mones S Abu-Asab
Journal:  Ultrastruct Pathol       Date:  2018-02-08       Impact factor: 1.094

6.  Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling.

Authors:  Xu-Wei Zhou; Yuan-Zheng Xia; Ya-Long Zhang; Jian-Guang Luo; Chao Han; Hao Zhang; Chao Zhang; Lei Yang; Ling-Yi Kong
Journal:  Oncotarget       Date:  2017-10-19

7.  Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden.

Authors:  Fernando Revert; Francisco Revert-Ros; Raül Blasco; Aida Artigot; Ernesto López-Pascual; Roberto Gozalbo-Rovira; Ignacio Ventura; Elain Gutiérrez-Carbonell; Nuria Roda; Daniel Ruíz-Sanchis; Jerónimo Forteza; Javier Alcácer; Alejandra Pérez-Sastre; Ana Díaz; Enrique Pérez-Payá; Juan F Sanz-Cervera; Juan Saus
Journal:  Oncotarget       Date:  2018-01-19

Review 8.  The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1).

Authors:  Marthe-Susanna Wegner; Lisa Gruber; Peter Mattjus; Gerd Geisslinger; Sabine Grösch
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

9.  Sex-, feeding-, and circadian time-dependency of P-glycoprotein expression and activity - implications for mechanistic pharmacokinetics modeling.

Authors:  Alper Okyar; Swati A Kumar; Elisabeth Filipski; Enza Piccolo; Narin Ozturk; Helena Xandri-Monje; Zeliha Pala; Kristin Abraham; Ana Rita Gato de Jesus Gomes; Mehmet N Orman; Xiao-Mei Li; Robert Dallmann; Francis Lévi; Annabelle Ballesta
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

Review 10.  Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors.

Authors:  Milan Hano; Lenka Tomášová; Mário Šereš; Lucia Pavlíková; Albert Breier; Zdena Sulová
Journal:  Molecules       Date:  2018-02-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.